Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Emgality ® ▼ (galcanezumab)
Emgality®▼ (galcanezumab): Travelling with the Device
The following travel guidance applies to patients that use Emgality devices (pre-filled pens and syringes).
Emgality may be stored unrefrigerated for single period up to 7 days when stored at temperatures up to 30 °C. If the device is stored at a higher temperature or for a longer period it must be discarded.1
The device should not be returned to the refrigerator once it was stored at room temperature. It should be used within the 7 days period.2
While travelling it is recommended the patient carries the medicine with him all times (e.g. plane, car, bus, train, etc.).2
The medicines should never be packed in with checked luggage. It is possible for luggage hold areas to have wide changes in temperatures. These temperatures may become too cold or too hot and this will affect the medicine.2
While travelling it is important to keep the medicine as cool as possible. To store at 2°C to 8°C is the best temperature to protect the medicine. It should not be frozen as this can damage the medicine and the device. It should be stored in the original package in order to protect from light.1
Travel Cooler Bags
Lilly does not provide cooler bags to travel with the device. Please refer to a pharmacist to discuss available equipment suitable to keep the medicine cool while traveling. Lilly does not test, market or sell these products, therefore, we cannot make recommendations.2
If the patient uses a cooler it is important to keep the device away from direct contact with ice, frozen gel packs or freezing temperatures (0°C or below). The medicine shall always be protected from light and freezing temperatures.2
Impact of Altitude
Changes in altitude that may be experienced when travelling do not impact the dose accuracy of the device.2
Airport Screening/X-ray Impact
The screening equipment used at airports (X-rays) are not known to affect the medicine. If preferred, the medicines and supplies can be inspected by hand when the patient goes through security checkpoints, on request.2
Before travelling the patient should check with the airline company to find out what the current travel policies are for travelling with medicine on board the plane. If travelling internationally, the patient should also check with the authorities in the country he plans to visit.2
2. Data on file, Eli Lilly and Company and/or one of its subsidiaries.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Date of Last Review: February 13, 2019